| Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer. (NCT07425548) | Institut Bergonié | 2026-04-01 |
| Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma (NCT06705335) | Institut Bergonié | 2026-03-27 |
| MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. (NCT05888857) | Institut Bergonié | 2025-09-01 |
| Streamlined Geriatric and Oncological Evaluation Based On IC Technology (NCT05720910) | Institut Bergonié | 2024-10-15 |
| Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures (NCT06084689) | Institut Bergonié | 2024-06-14 |
| Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours (NCT06540846) | Institut Bergonié | 2023-12-01 |
| Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer. (NCT06700057) | Institut Bergonié | 2023-11-01 |
| Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer (NCT05572476) | Institut Bergonié | 2023-10-01 |
| Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene (NCT05630105) | Institut Bergonié | 2023-06-12 |
| Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer (NCT05346848) | Institut Bergonié | 2023-02-24 |
| Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer. (NCT05690828) | Institut Bergonié | 2023-02-01 |
| Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) (NCT04968106) | Institut Bergonié | 2022-12-07 |
| Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management (NCT05415527) | Institut Bergonié | 2022-06-11 |
| Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas (NCT05182164) | Institut Bergonié | 2022-04-25 |
| Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma (NCT04874311) | Institut Bergonié | 2022-03-01 |
| Targeting ATR in Soft-tissue Sarcomas (NCT04807816) | Institut Bergonié | 2022-02-09 |
| Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients (NCT04912687) | Institut Bergonié | 2022-01-01 |
| Health Literacy and Digital Health in Cancer Patients. (NCT05070897) | Institut Bergonié | 2021-09-27 |
| Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR) (NCT04250766) | Institut Bergonié | 2021-09-07 |
| Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients (NCT04880382) | Institut Bergonié | 2021-08-27 |
| Combining Epigenetic And Immune Therapy to Beat Cancer. (NCT04705818) | Institut Bergonié | 2021-07-23 |
| Remote Monitoring for Ambulatory Care of Elderly Patients With Cancer (NCT04913259) | Institut Bergonié | 2021-06-15 |
| Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery (NCT04906187) | Institut Bergonié | 2021-05-31 |
| Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (NCT03915678) | Institut Bergonié | 2021-03-31 |
| Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study (NCT04258137) | Institut Bergonié | 2020-09-04 |
| Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma (NCT04339218) | Institut Bergonié | 2020-08-28 |
| Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic (NCT04426006) | Institut Bergonié | 2020-06-18 |
| Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study (NCT04095208) | Institut Bergonié | 2020-02-27 |
| Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients (NCT04008238) | Institut Bergonié | 2020-01-06 |
| Brief Intervention for Tobacco and Alcohol Risk Reduction for Couple During Breast Cancer Treatment. (NCT04007549) | Institut Bergonié | 2019-10-01 |
| Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin (NCT03960021) | Institut Bergonié | 2019-03-04 |
| Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas (NCT03805022) | Institut Bergonié | 2019-02-14 |
| Sample Size for Multivariate Time-to-event Data (NCT03964402) | Institut Bergonié | 2019-01-01 |
| MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii (NCT04053114) | Institut Bergonié | 2019-01-01 |
| High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study (NCT03342625) | Institut Bergonié | 2018-06-07 |
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (NCT03475953) | Institut Bergonié | 2018-05-04 |
| Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over (NCT03077178) | Institut Bergonié | 2017-11-30 |
| Circulating Tumor DNA After Neoadjuvant Chemotherapy (NCT03357120) | Institut Bergonié | 2017-10-06 |
| Assessing Patient-reported & Patient-related Outcomes in Randomized Cancer Trials for Older Adults (NCT03676218) | Institut Bergonié | 2017-09-01 |